NCT05178979Completed
A Gender Transformative Implementation Strategy With Providers to Improve HIV Outcomes in Uganda
A Gender Transformative Implementation Strategy With Providers to Improve HIV
Source: ClinicalTrials.gov · Last updated 25 Apr 2025
Brief summary (registry, in English)
Gender norms embedded in the health-system and broader community shape patient-provider relationships in ways that may undermine the provision of antiretroviral treatment (ART) counseling for men and women in Uganda. This study seeks to develop and evaluate the acceptability, feasibility, and preliminary efficacy of an innovative gender transformative implementation strategy to improve HIV provider capacity for equitable HIV care and ART adherence counseling.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 382 (actual)
- First submitted
- 15 Nov 2021
- Start date
- 31 Dec 2021
- Primary completion date
- 31 Jan 2024
- Lead sponsor
- The University of Texas at San Antonio
- Diseases
- HIV
- NCT number
- NCT05178979
What you commit to
- Study type: Interventional
- Participants enrolled: 382
- From 31 Dec 2021 to the primary completion date, 31 Jan 2024
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Who the study is looking for
- HIV care provider at the selected clinics, including HIV medical and clinical officers, nurses, midwives, linkage facilitators, counselors.
- 18 years of age or older
- Fluent in English or Luganda
- Patient Cohort:
- HIV-infected
- Enrolled in care at the clinic of recruitment
- pre-ART (newly diagnosed) or newly initiated on ART (within 3 months-1 year) or struggling with treatment adherence, defined in two ways: (1) most recent viral load results unsuppressed as assessed through clinic records; (2) or self-reported non-adherence as by the Adult AIDS Clinical Trials Group (AACTG) scale 4-day adherence recall questions. This scale has demonstrated good construct validity in Uganda and strong correlations with viral load;
- 18 years of age or an emancipated minor
- Fluent in Luganda or English
Criteria the registry did not label
- Provider Cohort:
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Luwero Health HCIV Coordinator of this site? Confirm its status | Luwero | Uganda | Unknown status |
| Namayumba Health HCIV Coordinator of this site? Confirm its status | Namayumba | Uganda | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.